AP9400679A0 - Method of inhibiting binding of reticulocytes to endothelium by interfering with VLA-4/VCAM-1 interactions. - Google Patents

Method of inhibiting binding of reticulocytes to endothelium by interfering with VLA-4/VCAM-1 interactions.

Info

Publication number
AP9400679A0
AP9400679A0 APAP/P/1994/000679A AP9400679A AP9400679A0 AP 9400679 A0 AP9400679 A0 AP 9400679A0 AP 9400679 A AP9400679 A AP 9400679A AP 9400679 A0 AP9400679 A0 AP 9400679A0
Authority
AP
ARIPO
Prior art keywords
reticulocytes
vcam
vla
endothelium
interfering
Prior art date
Application number
APAP/P/1994/000679A
Other languages
English (en)
Inventor
Robert A Swerlick
James R Eckman
Timothy M Wick
Original Assignee
Univ Emory
Georgia Tech Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory, Georgia Tech Res Inst filed Critical Univ Emory
Publication of AP9400679A0 publication Critical patent/AP9400679A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70542—CD106
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2842—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
APAP/P/1994/000679A 1993-09-15 1994-09-13 Method of inhibiting binding of reticulocytes to endothelium by interfering with VLA-4/VCAM-1 interactions. AP9400679A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12222893A 1993-09-15 1993-09-15

Publications (1)

Publication Number Publication Date
AP9400679A0 true AP9400679A0 (en) 1996-03-13

Family

ID=22401460

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000679A AP9400679A0 (en) 1993-09-15 1994-09-13 Method of inhibiting binding of reticulocytes to endothelium by interfering with VLA-4/VCAM-1 interactions.

Country Status (5)

Country Link
EP (1) EP0720486A1 (fr)
AP (1) AP9400679A0 (fr)
AU (1) AU7835294A (fr)
WO (1) WO1995007717A1 (fr)
ZA (1) ZA947006B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11560433B2 (en) * 2016-05-27 2023-01-24 Albert Einstein College Of Medicine Methods of treatment by targeting VCAM1 and MAEA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL113261A (en) * 1989-09-01 1996-10-16 Hutchinson Fred Cancer Res Inhibition by peptides of lymphocyte adherence to vascular endothelium utilizing an extracellular matrix receptor-ligand interaction and pharmaceutical compositions containing said peptides
CA2127462C (fr) * 1992-01-13 1999-03-23 Roy R. Lobb Traitement de l'asthme
JPH07506566A (ja) * 1992-02-12 1995-07-20 バイオゲン　インコーポレイテッド 炎症性胃腸病の処置

Also Published As

Publication number Publication date
WO1995007717A1 (fr) 1995-03-23
EP0720486A1 (fr) 1996-07-10
ZA947006B (en) 1995-05-02
AU7835294A (en) 1995-04-03

Similar Documents

Publication Publication Date Title
IL129056A0 (en) Monocyclic N-heterocyclics substituted by thio acid derivatives and pharmaceutical compositions containing same
MY102705A (en) Proline derivaties and related compounds.
ATE150975T1 (de) Peripheralisierung hämatopoietischer stammzellen
DE69500773D1 (de) Verfahren zur Vorbehandlung von H2S-haltigem Erdgas
ATE161536T1 (de) Neue mercaptoacetylamid-derivate zur verwendung als enkephalinase- und ace-hemmer
BR9815550A (pt) Método não biocida para inibir a geração de sulfeto biogênico
DE69133299D1 (de) Aminosulfonylcarbamate
FI953865L (fi) Rhodococcus rhodochrous-kanta nitriilihydrataasin tuottajana
HU9503370D0 (en) N-alkylthio polyamine derivatives as radioprotective agents
ES8506190A1 (es) Un metodo para estabilizar un activador de plasminogeno de tejido.
BG101892A (en) Sugar-modified cytostatics
NO961693L (no) Delta16-umettede C17-heterocykliske steroider som er anvendbare som steroid C17-20-lyaseinhibitorer
PL337658A1 (en) Additive used to extend shelf life and/or improve stability of microbiologically degradable products
TW249202B (fr)
KR840006128A (ko) 동물의 성장촉진제
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
ATE292547T1 (de) Holzkonservierung unter verwendung polymerer phenolsulfide
GR3034900T3 (en) Method of cultivation of coal and lignite infields formed by uncovering (open cast mining).
BR9301612A (pt) Agente de protecao contra a corrosao e aplicacao
EP0604667A4 (fr) Derive d'acide tranexamique et preparation dermatologique le contenant.
ZA947006B (en) Method of inhibiting binding of reticulocytes to endothelium by interfering with vla-4/vcam-1 interactions
AU546507B2 (en) Acylated furanyl
EP0254049A3 (fr) Compositions herbicides
KR840004721A (ko) 5-옥소(oxo)-2-피롤리딘프로파노인산 유도체의 제조방법
DE68903028D1 (de) Verfahren zur chemisch-biologischen entschwefelung von kohle.